서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 13 of 13

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2005	Predictive and prognostic impact of epidermal growth factor receptor (EGFR) mutation in non-small-cell lung cancer (NSCLC) patients treated with gefitinib (ZD1839) 한세원	link
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2007-11	Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives Kim, Toe-You; Han, Soe-Won; Bang, Yung-Jue Expert Review of Molecular Diagnostics, Vol.7 No.6, pp.821-836	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2009	Erlotinib after gefitinib failure in female never-smoker asian patients with pulmonary adenocavenoma 심성훈	link
2013-08	Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study Lee, J. K.; Shin, J. -Y.; Kim, S.; Lee, S.; Park, C.; Kim, J. -Y.; Koh, Y.; Keam, B.; Min, H. S.; Kim, T. M.; Jeon, Y. -K.; Kim, D. -W.; Chung, D. H.; Heo, D. S.; Lee, S. -H.; Kim, J. -I. Annals of Oncology, Vol.24 No.8, pp.2080-2087	DOI
2014-02	Identification of predictive biomarkers and the mechanisms of acquired resistance to epidermal growth factor receptor inhibitors 김황필	view file
2014-02	Gefitinib-induced Interstitial Lung Disease in Korean Lung Cancer Patients 범승훈	view file
2015-08	Total lesion glycolysis in positron emission tomography can predict gefitinib outcomes in non-small-cell lung cancer with activating EGFR mutation Keam, Bhumsuk; Lee, Soo Jin; Kim, Tae Min; Paeng, Jin Chul; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon Kyung; Chung, Doo Hyun; Kang, Keon Wook; Chung, June-Key; Heo, Dae Seog Journal of Thoracic Oncology, Vol.10 No.8, pp.1189-1194	DOI
2017-02	Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial Paz-Ares, L.; Tan, E. -H.; O'Byrne, K.; Zhang, L.; Hirsh, V.; Boyer, M.; Yang, J. C. -H.; Mok, T.; Lee, K. H.; Lu, S.; Shi, Y.; Lee, D. H.; Laskin, J.; Kim, D. -W.; Laurie, S. A.; Kolbeck, K.; Fan, J.; Dodd, N.; Marten, A.; Park, K. Annals of Oncology, Vol.28 No.2, pp.270-277	DOI
2017-02	A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Kim, Hye Ryun; Jang, Joung Soon; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Jung, Inkyung; Lee, Ki Hyeong; Kim, Joo-Hang; Lee, Dae Ho; Kim, Sang-We; Cho, Byoung Chul Oncotarget, Vol.8 No.9, pp.15943-15951	DOI
2020	Autophagy contributes to the insensitivity to gefitinib in ovarian cancer cells with wild-type EGFR 이지현	view file link

1